Overexpression of IL-13 in Patients With Bladder Cancer

REFERENCES

• Mitra, A.P.; Datar, R.H.; Cote, R.J. Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification. J Clin Oncol 2006, 24, 5552–5564.
   PubMed Web of Science ®Google Scholar
• Bladder Cancer. Cancer Research U K website. Available at: http://info.cancerresearchuk.org/cancerstats/types/bladder/?a=5441. Accessed, 2007..
   Google Scholar
• Riedel, F.; Adam, S.; Feick, P.; Haas, S. Expression of il-18 in patients with head and neck squamous cell carcinoma. Int J Mol Med 2004, 13, 267–272.
   PubMed Web of Science ®Google Scholar
• Kawabata, T.; Ichikura, T.; Majima, T.; Seki, S.; Chochi, K.; Takayama, E.; Hiraide, H.; Mochizuki, H. Preoperative serum interleukin-18 level as postoperative prognostic marker in patients with gastric carcinoma. Cancer 2001, 92, 2050–2055.
   PubMed Web of Science ®Google Scholar
• Gastl, G.A.; Abrams, J.S.; Nanus, D.M.; Oosterkamp, R.; Silver, J.; Liu, F.; Chen, M.; Albino, A.P.; Bander, N.H. Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression. Int J Cancer 1993, 55, 96–101.
   PubMed Web of Science ®Google Scholar
• Joshi, B.H.; Puri, R.K. Optimization of expression and purification of two biologically active chimeric fusion proteins that consist of human interleukin-13 and Pseudomonas exotoxin in Escherichia coli. Protein Expr Purif 2005, 39(2), 189–198.
   PubMed Web of Science ®Google Scholar
• Opal, S.M.; Vera, A.; De Palo, V.A. Anti-inflammatory cytokines. Chest 2000, 117, 1162–1172.
   PubMed Web of Science ®Google Scholar
• Di Santo, E.; Meazza, C.; Sironi, M.; Fruscella, P.; Mantovani, A.; Sipe, J.D.; Ghezzi, P. IL-13 inhibits TNF production but potentiates that of IL-6 in vivo and ex vivo in mice. J Immunol 1997, 159, 379–382.
   PubMed Web of Science ®Google Scholar
• Mijarovic, T.; Kruy, V.; Caput, D.; Defrance, P.; Huez, G. Interleukin-4 and -13 inhibit tumor necrosis factor-a mRNA translational activation in lipopolysaccharide-induced mouse macrophages. J Biol Chem 1997, 272, 14394–14398.
   PubMed Web of Science ®Google Scholar
• Muchamuel, T.; Menon, S.; Pisacane, P.; Howard, M.C.; Cockayne, D.A. IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia: correlation with down-modulation of TNF-a, IFN-g, and IL-12 production. J Immunol 1997, 158, 2898–2903.
   PubMed Web of Science ®Google Scholar
• Mulligan, M.S.; Warner, R.L.; Foreback, J.L.; Shanley, T.P.; Ward, P.A. Protective effects of IL- 4, IL-10, IL-12, and IL-13 in IgG immune complex-induced lung injury: role of endogenous IL-12. J Immunol 1997, 159, 3483–3489.
   PubMed Web of Science ®Google Scholar
• Lentsch, A.B.; Czermak, B.J.; Bless, N.M.; Ward, P.A. NF-kB activation during IgG immune complex-induced lung injury: requirements for TNF-α and IL-1β but not complement. Am J Pathol 1998, 152, 1327–1336.
   PubMed Web of Science ®Google Scholar
• Hauber, H.-P.; Gholami, D.; Meyer, A.; Pforte, A. Increased interleukin-13 expression in patients with sarcoidosis. Thorax 2003, 58, 519–524.
   PubMed Web of Science ®Google Scholar
• Mishina, D.; Katsel, P.; Brown, S.T.; Gilberts, E.C.A.M.; Greenstein, R.J. On the etiology of Crohn disease. Proc Natl Acad Sci USA 1996, 93, 9816–9820.
   PubMed Web of Science ®Google Scholar
• Tineke, C.T.M.; van der Pouw, K.; Boeije, L.C.M.; Troon, J.T.M.; Rutschmann, S.K.; Wijdenes, J.; Aarden, L.A. Human IL-13 production is negatively influenced by CD3 engagement, enhancement of IL-13 production by cyclosporin A. J Immunol 1996, 156, 1818–1823.
   PubMed Web of Science ®Google Scholar
• McKenzie, A.N.; Li, X.; Largaespada, D.A.; Sato, A.; Kaneda, A.; Zurawski, S.M.; Doyle, E.L.; Milatovich, A.; Francke, U.; Copeland, N.G. Structural comparison and chromosome localization of the human and mouse 1L-13 genes. J Immunol 1993, 150, 5436–5444.
   PubMed Web of Science ®Google Scholar
• Deepak, P.; Kumar, S.; Acharya, A. Interleukin-13-induced type II polarization of inflammatory macrophages is mediated through suppression of nuclear factor-kappaB and preservation of IkappaBalpha in a T cell lymphoma. Clin Exp Immunol 2007, 149(2), 378–386.
   PubMed Web of Science ®Google Scholar
• Ahn, K.S.; Aggarwal, B.B. Transcription factor NF-kappaB: a sensor for smoke and stress signals. Ann N Y Acad Sci 2005, 1056, 218–233.
   PubMed Web of Science ®Google Scholar
• Minty, A.; Chalon, P.; Derocq, J.M.; Dumont, X.; Guillemot, J.C.; Kaghad, M.; Labit, C.; Leplatois, P.; Liauzun, P.; Milloux, B. Interlenkin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993, 362, 24.
   PubMedGoogle Scholar
• Fior, R.; Vita, N.; Raphael, M.; Minty, A.; Maillot, M.C.; Crevon, M.C.; Caput, D.; Biberfeld, P.; Ferrara, P.; Galanaud, P. Interleukin-13 gene expression by malignant and EBV-transformed human B lymphocytes. Eur Cy Tokine Netw 1994, 5, 593–598.
   PubMed Web of Science ®Google Scholar
• Burd, P.R.; Thompson, W.C.; Max, E.E.; Mills, F.C. Activated mast cells produce interleukin 13. J Exp Med 1995, 18, 1373.
   Google Scholar
• Cosentino, G.; Soprana, E.; Thienes, C.P.; Siccardi, A.G.; Viale, G.; Vercelli, D IL-13 down-regulates CD 14 expression and TNF-a secretion in normal human monocytes. J Immunol 1995, 155, 3145–3151.
   PubMed Web of Science ®Google Scholar
• Sasaki, K.; Zhu, X.; Vasquez, C.; Nishimura, F.; Dusak, J.E.; Huang, J.; Fujita, M.; Wesa, A.; Potter, D.M.; Walker, P.R.; Storkus, W.J.; Okada, H. Preferential expression of very late antigen-4 on type 1 CTL cells plays a critical role in trafficking into central nervous system tumors. Cancer Res 2007, 67(13), 6451–6458. .
   PubMed Web of Science ®Google Scholar
• Lee, C.G.; Homer, R.J.; Zhu, Z.; Lanone, S.; Wang, X.; Koteliansky, V.; Shipley, J.M.; Gotwals, P.; Noble, P.; Chen, Q.; Senior, R.M.; Elias, J.A. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J Exp Med 2001, 194, 809–821.
   PubMed Web of Science ®Google Scholar
• Robergea, F.G.; de Smeta, M.D.; Benichoub, J.; Krietea, M.F.; Rabera, J.; Hakimic, J. Treatment of uveitis with recombinant human interleukin-13. Br J Ophthalmol 1998, 82, 1195–1198.
   PubMed Web of Science ®Google Scholar
• Watson, M.L.; White, A.M.; Campbell, E.M.; Smith, A.W.; Uddin, J; Yoshimura, T; Westwick, J Anti-inflammatory actions of interleukin-13: suppression of tumor necrosis factor-alpha and antigen-induced leukocyte accumulation in the guinea pig lung. Am J Respir Cell Mol Biol 1999, 20, 1007–1012.
   PubMed Web of Science ®Google Scholar
• Zhou, Z.; Homer, R.J.; Wang, Z.; Chen, Q.; Geba, G.P.; Wang, J.; Zhang, Y.; Elias, J.A. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999, 103, 779–788.
   PubMed Web of Science ®Google Scholar
• Joshi, B.H.; Hogaboam, C.; Dover, P.; Husain, S.R.; Puri, R.K. Role of interleukin-13 in cancer, pulmonary fibrosis, and other T(H)2-type diseases. Vitam Horm 2006, 74, 479–504.
   PubMed Web of Science ®Google Scholar
• Aspord, C.; Pedroza-Gonzalez, A.; Gallegos, M.; Tindle, S.; Burton, E.C.; Su, D.; Marches, F.; Banchereau, J.; Palucka, A.K. Breast cancer instructs dendritic cells to prime interleukin 13–secreting CD4+ T cells that facilitate tumor development. J Exp Med 2007, 204(5), 1037–1047.
   PubMed Web of Science ®Google Scholar